News – Dr Michael Forstner presenting at the DIA 2019 Global Annual Meeting as an expert in lifecycle Benefit-Risk management
Published 3 June 2019.
We are very pleased to share that Dr. Michael Forstner, Senior VP and Head of Pharmacoepidemiology & Risk Management, will give a lecture at the upcoming #DIA2019.
On Tuesday, June 25th at 8 am at the San Diego Convention Center.
Dr Forstner will be part of the #202: Updates and Lessons Learned from Novel Approaches to Pharmacovigilance Collaboration panel and his presentation will be about : “ The European IV Iron PASS Consortium: Experiences from Coordinating a Multi-Company, Multi-Registry PASS“.
Dr. Forstner will be sharing lessons learned from setting up and coordinating the consortium, dealing with various health authorities, member companies and research partners, and operational issues that need to be considered when performing such a study.
The presentation will be followed by a round table discussion on the same day at 3:15 pm: #276 RT
The PrimeVigilance Team is looking forward to be attending the DIA Annual meeting where everyone passionate about innovation at the interface of drug development, regulatory sciences, and global healthcare meets.
If you would like to reach out to Dr. Forstner or our team for a meeting during the event, please contact us at email@example.com
For more information about the #DIA2019 in San Diego, please visit their website
About the DIA Annual Meeting
It is the largest, longest-running event in the life sciences industry, this gathering is designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. The DIA 2019 Global Annual Meeting will host thousands of professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe and 400+ exhibiting companies.